INNOCAN PHARMA CORPO

INNO
Delayed Quote. Delayed  - 09/24 03:59:56 pm
1CAD +1.01%

Turn to zoom
Prev.0.9900
Open0.9600
High1.0400
Low0.8600
Volume224 630
Latest news
09/06
09/03
09/03
09/03
Chart INNOCAN PHARMA CORPORATION
Financials
Sales 2020 0,01  - -
Net income 2020 -9,95 M - -
Net cash 2020 2,30 M - -
P/E ratio 2020 -5,45x
Yield 2020 -
Capitalization 185 M 184 M -
EV / Sales 2019 -
EV / Sales 2020 5 844 626 693x
Nbr of Employees -
Free-Float 71,6%
Company
Innocan Pharma Corporation is an Israel-based pharmaceutical company active in the medical cannabis industry. It operates through three distinct operating segments: Research, Development, Marketing, Distribution and sales of InnoCan-branded over the counter (OTC) pharmaceutical products; Research...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
No events available

Income Statement Evolution